BACKGROUND: Advances in antiretroviral therapy (ART) over the last decade have improved clinical outcomes for people living with human immunodeficiency virus (HIV), but whether these improvements are experienced by disadvantaged urban populations is less clear. METHODS: We evaluated mortality among a clinical cohort in a public safety-net HIV specialty clinic in San Francisco, California. RESULTS: Among 1651 ART-eligible patients attending an urban US HIV clinic, 4-year mortality was 10.0% in 2000-2004 and 11.0% in 2005-2009. Despite universal ART availability, only 72 (42%) of 172 patients who died, compared with 69% of survivors, ever achieved an HIV viral load, 400 copies per cubic millimeter. The leading causes of death were acquired immunodeficiency syndrome (56%), violence/overdose (16%), and pulmonary disease (6%). CONCLUSIONS: Disadvantaged subpopulations in the developed world can experience high mortality rates despite accessing specialty HIV clinical services with full ART availability. New strategies are needed to improve the outcomes in these populations.
BACKGROUND: Advances in antiretroviral therapy (ART) over the last decade have improved clinical outcomes for people living with human immunodeficiency virus (HIV), but whether these improvements are experienced by disadvantaged urban populations is less clear. METHODS: We evaluated mortality among a clinical cohort in a public safety-net HIV specialty clinic in San Francisco, California. RESULTS: Among 1651 ART-eligible patients attending an urban US HIV clinic, 4-year mortality was 10.0% in 2000-2004 and 11.0% in 2005-2009. Despite universal ART availability, only 72 (42%) of 172 patients who died, compared with 69% of survivors, ever achieved an HIV viral load, 400 copies per cubic millimeter. The leading causes of death were acquired immunodeficiency syndrome (56%), violence/overdose (16%), and pulmonary disease (6%). CONCLUSIONS: Disadvantaged subpopulations in the developed world can experience high mortality rates despite accessing specialty HIV clinical services with full ART availability. New strategies are needed to improve the outcomes in these populations.
Authors: Margot B Kushel; Judith A Hahn; Jennifer L Evans; David R Bangsberg; Andrew R Moss Journal: Am J Public Health Date: 2005-10 Impact factor: 9.308
Authors: Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland Journal: Lancet Date: 2010-07-31 Impact factor: 79.321
Authors: Rebecca K Lodwick; Caroline A Sabin; Kholoud Porter; Bruno Ledergerber; Ard van Sighem; Alessandro Cozzi-Lepri; Pavel Khaykin; Amanda Mocroft; Lisa Jacobson; Stephane De Wit; Niels Obel; Antonella Castagna; Jan-Christian Wasmuth; John Gill; Marina B Klein; Stephen Gange; Melchor Riera; Cristina Mussini; Félix Gutiérrez; Giota Touloumi; Patrizia Carrieri; Jodie L Guest; Norbert H Brockmeyer; Andrew N Phillips Journal: Lancet Date: 2010-07-15 Impact factor: 79.321
Authors: Andrew R Moss; Judith A Hahn; Sharon Perry; Edwin D Charlebois; David Guzman; Richard A Clark; David R Bangsberg Journal: Clin Infect Dis Date: 2004-09-27 Impact factor: 9.079
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Jo Kimber; Lorraine Copeland; Matthew Hickman; John Macleod; James McKenzie; Daniela De Angelis; James Roy Robertson Journal: BMJ Date: 2010-07-01
Authors: Mari M Kitahata; Benigno Rodriguez; Richard Haubrich; Stephen Boswell; W Christopher Mathews; Michael M Lederman; William B Lober; Stephen E Van Rompaey; Heidi M Crane; Richard D Moore; Michael Bertram; James O Kahn; Michael S Saag Journal: Int J Epidemiol Date: 2008-02-08 Impact factor: 7.196
Authors: Zian H Tseng; Eric A Secemsky; David Dowdy; Eric Vittinghoff; Brian Moyers; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue Journal: J Am Coll Cardiol Date: 2012-05-22 Impact factor: 24.094
Authors: Tessa M Nápoles; Abigail W Batchelder; Ada Lin; Lissa Moran; Mallory O Johnson; Martha Shumway; Anne F Luetkemeyer; Marion G Peters; Kellene V Eagen; Elise D Riley Journal: J Public Health (Oxf) Date: 2019-12-20 Impact factor: 2.341
Authors: Katerina A Christopoulos; Susan Scheer; Wayne T Steward; Revery Barnes; Wendy Hartogensis; Edwin D Charlebois; Stephen F Morin; Hong-Ha M Truong; Elvin H Geng Journal: J Acquir Immune Defic Syndr Date: 2015-05-01 Impact factor: 3.731
Authors: Katerina A Christopoulos; William E Cunningham; Curt G Beckwith; Irene Kuo; Carol E Golin; Kevin Knight; Patrick M Flynn; Anne C Spaulding; Lara S Coffin; Bridget Kruszka; Ann Kurth; Jeremy D Young; Sharon Mannheimer; Heidi M Crane; Shoshana Y Kahana Journal: AIDS Behav Date: 2017-11
Authors: Sandra Schwarcz; Nancy A Hessol; Matthew A Spinelli; Ling Chin Hsu; Daniel Wlodarczyk; Jacqueline Tulsky; Meg D Newman; Susan P Buchbinder Journal: Public Health Rep Date: 2021-02-04 Impact factor: 3.117
Authors: Mojtaba Akbari; Mohammad Fararouei; Ali Akbar Haghdoost; Mohammad Mahdi Gouya; Parvin Afsar Kazerooni Journal: J Res Med Sci Date: 2019-01-31 Impact factor: 1.852